Key result
Axillobifemoral bypass succeeds as a bailout for severe aortoiliac disease when standard bypass proves unfeasible.
Why the study?
Axillobifemoral bypass is used as a bailout procedure in patients with severe aortoiliac disease when standard aortobifemoral bypass is difficult to perform due to local complications.
Case Report (n=1)
Axillobifemoral bypass can serve as an effective bailout procedure for patients with severe aortoiliac disease when standard aortobifemoral bypass is intraoperatively deemed difficult.
Answers are grounded in this paper and cite their sources.
May support axillobifemoral bypass as bailout in select cases; leaves open broader role without prospective data.
Peripheral artery disease (PAD) affects over 200 million adults globally, with its incidence rising to around 20% among individuals over 70 years old. Smoking multiplies the risk of developing PAD by four and has a significant impact on the severity of the disease. Smokers with PAD tend to have shorter lifespans and are more likely to experience critical limb ischemia and require amputation compared to nonsmokers. We have presented a case report of a young male who was diagnosed as a case of Peripheral artery disease with thrombosis of the infra-renal aorta with blockage of the bilateral common iliac artery (TASC type D lesion). The patient was planned for an Aortobifemoral bypass, but intraoperative findings compelled us to change the course of action to an Axillobifemoral bypass. Axillobifemroal bypass is done in only 13.4% of the patient of total number of patients undergoing surgical bypass for Peripheral artery disease. It is done for patients with local issues that complicate standard aorta-femoral reconstruction, such as previous aortoiliac surgeries, prior radiation treatments, extensive intraabdominal adhesions, severe calcification of the aorta, abdominal malignancies, intra-abdominal infections, infections of the aorta or an aortic graft, colostomy or ileostomy, and enterocutaneous fistulas. Recent studies have suggested that the five-year patency rate of Axilofemroral bypass surgeries is 83.7%, comparable to aortobifemoral bypass. Axillobifemroal bypass has comparable results in terms of a five-year patency rate and can done in patients for whom aortobifemoral bypass is difficult to perform.
No takes yet. Share an insight, caveat, or question.
Yusufi et al. (2025) conducted a case report in Peripheral artery disease with severe aortoiliac disease (n=1). Axillobifemoral bypass was evaluated. Axillobifemoral bypass was successfully utilized as a bailout procedure in a young male with severe aortoiliac disease when standard aortobifemoral bypass was intraoperatively deemed unfeasible.
Synapse has enriched 10 related papers. Consider them for comparative context: